Viewing Study NCT02966093


Ignite Creation Date: 2025-12-25 @ 1:14 AM
Ignite Modification Date: 2025-12-27 @ 1:33 AM
Study NCT ID: NCT02966093
Status: COMPLETED
Last Update Posted: 2022-01-26
First Post: 2016-11-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Trial of Lenvatinib (E7080) in Radioiodine (131 I)-Refractory Differentiated Thyroid Cancer in China
Sponsor: Eisai Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module